Matt Kaplan's Insider Trades & SAST Disclosures

Matt Kaplan's most recent trade in Great Elm Capital Corp was a trade of 19,650 Common Stock done at an average price of $7.6 . Disclosure was reported to the exchange on Nov. 7, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Great Elm Cap Corp
Matt Kaplan CEO and President Purchase of securities on an exchange or from another person at price $ 7.64 per share. 07 Nov 2025 19,650 142,400 (1%) 0% 7.6 150,126 Common Stock
Nuvectis Pharma Inc
Matthew L. Kaplan Director Purchase of securities on an exchange or from another person at price $ 5.84 per share. 05 Nov 2025 11,000 124,760 - 5.8 64,240 Common Stock
Great Elm Cap Corp
Matt Kaplan CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2025 37,117 129,906 (1%) 0% 0 Common Stock
Great Elm Cap Corp
Matt Kaplan CEO and President Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.43 per share. 19 Sep 2025 8,211 122,750 (1%) 0% 11.4 93,852 Common Stock
Great Elm Cap Corp
Matt Kaplan CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Sep 2025 1,055 130,961 (1%) 0% 0 Common Stock
Nuvectis Pharma Inc
Matthew L. Kaplan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2025 30,000 113,760 - 0 Common Stock
Great Elm Cap Corp
Matt Kaplan CEO and President Other type of transaction at price $ 0.00 per share. 20 Sep 2024 42,121 92,789 (0%) 0% 0 Common Stock
Nuvectis Pharma Inc
Matthew L. Kaplan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 30,000 83,760 - 0 Common Stock
Nuvectis Pharma Inc
Matthew L. Kaplan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 18,000 53,760 - 0 Common Stock
Great Elm Cap Corp
Matt Kaplan CEO and President Purchase of securities on an exchange or from another person at price $ 9.29 per share. 10 Mar 2023 1,100 12,000 (0%) 0% 9.3 10,219 Common Stock
Great Elm Cap Corp
Matt Kaplan CEO and President Purchase of securities on an exchange or from another person at price $ 9.13 per share. 07 Mar 2023 5,020 7,020 (0%) 0% 9.1 45,833 Common Stock
Great Elm Cap Corp
Matt Kaplan CEO and President Purchase of securities on an exchange or from another person at price $ 9.46 per share. 07 Mar 2023 2,201 9,221 (0%) 0% 9.5 20,821 Common Stock
Great Elm Cap Corp
Matt Kaplan CEO and President Purchase of securities on an exchange or from another person at price $ 9.41 per share. 07 Mar 2023 1,679 10,900 (0%) 0% 9.4 15,799 Common Stock
Great Elm Cap Corp
Matt Kaplan CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.50 per share. 15 Jun 2022 1,000 2,000 (0%) 0% 12.5 12,500 Common Stock
Great Elm Cap Corp
Matt Kaplan CEO and President Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2022 1,000 0 - - Subscription Rights
Nuvectis Pharma Inc
Matthew L. Kaplan Director Purchase of securities on an exchange or from another person at price $ 17.47 per share. 12 May 2022 1,823 35,760 - 17.5 31,848 Common Stock
Nuvectis Pharma Inc
Matthew L. Kaplan Director Purchase of securities on an exchange or from another person at price $ 15.96 per share. 12 May 2022 1,177 33,937 - 16.0 18,785 Common Stock
Nuvectis Pharma Inc
Matthew L. Kaplan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2022 15,000 15,000 - - Stock Options (right to buy)
Great Elm Cap Corp
Matt Kaplan CEO and President Purchase of securities on an exchange or from another person at price $ 14.00 per share. 08 Mar 2022 1,000 1,000 (0%) 0% 14 14,000 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades